Acid/Base & electrolytes Flashcards

1
Q

Information Obtained from an ABG

A
Acid base status
Oxygenation
        Dissolved O2 (pO2)
        Saturation of hemoglobin
CO2 elimination, aka ventilation
Levels of carboxyhemoglobin & methemoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contraindications for an ABG

A

Bleeding diathesis
AV fistula
Severe peripheral vascular disease, absence of an arterial pulse
Infection over site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications for ABG

A

Assess the ventilatory status, oxygenation and acid base status
Assess the response to an intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pulse Oximetry

A

Oximetry is non-invasive & provides immediate and continuous data
Oximetry does not assess ventilation (pCO2) or acid base status
Oximetry unreliable when pO2 < 70-80%
Pulse oximetry cannot interpret methemoglobin or carboxyhemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

metabolic acidosis

A
pH= low
HCO3= low
PaCO2= low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

metabolic alkalosis

A
pH= high
HCO3= high
PaCO2= high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

respiratory alkalosis

A
pH= high
HCO3= low
PaCO2= low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

respiratory acidosis

A
pH= low
HCO3= high
PaCO2= high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phase 1 for Salicylate Toxicity

A

hyperventilation resulting from direct respiratory center stimulation w/ respiratory alkalosis and compensatory alkaluria. K and NaCO3 excreted in the urine. Lasts as long as 12 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phase 2 for Salicylate Toxicity

A

paradoxic aciduria in the presence of continued respiratory alkalosis occurs when sufficient potassium has been lost from the kidneys. Begins w/ hours & may last 12-24 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phase 3 for Salicylate Toxicity

A

dehydration, hypokalemia, and progressive metabolic acidosis. Begins 4-6 hours after ingestion in a young infant or 24 hours or more after ingestion in an adolescent or adult.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

symptoms for salicylate toxicity

A

Nausea, vomiting, diaphoresis, and tinnitus are the earliest signs
Hyperthermia in severe toxicity, especially in young children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Etiology for respiratory alkalosis

A

CNS stimulation– pain, anxiety, fever
hypoxia–aspiration, PNA
drugs/hormones– pregnancy, cardiac failure
stimulation of chest receptors– flail chest, hemothorax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Etiology for respiratory acidosis

A
stroke 
infection
asthma
emphysema
bronchitis
muscular dystrophies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Severe hyponatremia

A

Sodium < 120 mEq/L
Symptoms to include mental status changes, seizure, or coma
Infusion of 3% hypertonic saline solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do you correct hyponatremia

A

hyperglycemia
Corrected Sodium (Hillier, 1999) = Measured sodium + 0.024 * (Serum glucose - 100)
Sodium correction factor of 2.4mEq/L per 100

17
Q

Etiology of hypokalemia

A
poor intake
increased sweating
V/D
cushing syndrome
magnesium depletion 
hypothermia
medications
18
Q

Etiology of hyperkalemia

A
Renal failure
Medications
Type IV renal tubular acidosis
increased potassium input
Hemolysis
Rhabdomyolysis
19
Q

Hypokalemia

A

Usually associated with diuretic therapy
Symptoms are primarily neuromuscular and cardiac
Assess acid–base status
Replace potassium orally whenever possible; IV potassium may be given with caution in severe cases with appropriate monitoring

20
Q

Hyperkalemia

A

true emergency
Suspect hyperkalemia in patients with renal failure, diabetes, or those taking potassium supplements
Symptoms are primarily neuromuscular and cardiac
EKG findings may progress rapidly from peaked T waves to ventricular fibrillation
Beware of spurious hyperkalemia
Treatment stabilizes cardiac membranes, shifts potassium into cells, and removes potassium from the body

21
Q

Etiology of Hypercalcemia

A
Hyperparathyroidism
Increased PTH-related protein in NSCLC, RCC, prostate ca., multiple myeloma
Milk-alkali syndrome
Thiazide diuretics
Granulomatous diseases
Vitamin D intoxication
22
Q

Hypocalcemia

A

Occurs often in critically ill patients, although rarely life-threatening in itself
Usually asymptomatic until severe
Neuromuscular and respiratory symptoms predominate
Often associated with disorders of magnesium and phosphate
Always check serum phosphate before replacing calcium IV
Use caution in giving IV calcium to patients taking digoxin

23
Q

Hypercalcemia

A

Usually caused by malignancy or hyperparathyroidism
Symptoms are primarily neuromuscular and renal
Volume replacement/expansion is primary therapy
Treatment promotes calcium excretion, inhibits osteoclast activity, and decreases calcium absorption

24
Q

Etiology of hyperphosphatemia

A
decreased absorption
renal losses
carbohydrate infusion
rapid cellular uptake
medication/ hormone effect
25
Q

Hypophosphatemia

A

Hypophosphatemia is often asymptomatic unless severe and commonly occurs along with disorders of calcium, magnesium, and potassium
Assess acid–base status
Oral replacement is preferred and should be initiated even in asymptomatic patients
IV replacement may be used cautiously in severely symptomatic patient

26
Q

Hyperphosphatemia

A

Hyperphosphatemia is often associated with renal disease or hypoparathyroidism
Increased phosphate may be a manifestation of tumor lysis or rhabdomyolysis
Initial treatment consists of volume expansion and using insulin and glucose to shift phosphate into cells

27
Q

Hypophosphatemia Treatment

A

Phosphate replacement appropriate regardless of symptoms
Oral supplementation is safe & preferred (milk contains 1 mg of phosphate/ml, or oral formulations containing sodium or potassium phosphate)
Severe symptomatic hypophosphatemia, IV infusion of sodium or potassium phosphate at a rate not to exceed 2.5 mg/kg over 6 hours

28
Q

Hyperphosphatemia Treatment

A

Normal renal function, volume expansion using isotonic saline coupled with acetazolamide (15 mg/kg, 500 mg in an average adult) will excrete phosphate: Ca may also be lowered
IV insulin and glucose to move phosphate into the cells (as with hyperkalemia)
Dialysis if renal failure
Chronic hyperphosphatemia - primary focus is reducing intestinal absorption

29
Q

Etiology of Hypomagnesemia

A
decreased intake
diarrhea
malabsorption
fistula
alcohol
medications
diuresis
30
Q

Hypomagnesemia

A

Frequently associated with disorders of calcium, potassium, and phosphate
Common in malnourished patients and those with renal disease
Symptoms are primarily neuromuscular and similar to those seen with hypocalcemia
Oral replacement is preferred except in severe symptomatic cases

31
Q

Hypermagnesemia

A

Symptoms are rare until magnesium levels are severely elevated
Usually secondary to renal failure or excess magnesium intake
Calcium gluconate can be used to reverse respiratory paralysis until forced diuresis or dialysis lowers serum magnesium levels

32
Q

Hypomagnesemia Treatment

A
correction of electrolytes
oral replacement for mild symptoms- mag oxide/ gluconate
parenteral therapy for symtpoms 
magsulfate in 20% solution
with renal failure mag should be halved
33
Q

Hypermagnesemia Treatment

A

Calcium gluconate as temporizing measure in cases of impending respiratory paralysis
Patients with normal renal function should undergo forced diuresis with isotonic saline and furosemide to promote renal excretion
Dialysis is indicated for severe hypermagnesemia and renal insufficiency